Nada M. Mohamed

Dr. Nada M. Mohamed

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2017 in Archiv der Pharmazie
Verified
Journal Article
Closed access
PDF file
KAKamilia M. Amin
Kamilia M. Amin
ATAly M. Taha
Aly M. Taha
RGRiham F. George
Riham F. George
NMNada M. Mohamed
Nada M. Mohamed
Fardous F. El-SendunyFardous F. El-Senduny
Fardous F. El-Senduny

12 June 2024 in RSC Advances
Verified
Journal Article
Open access
PDF file
SBSamir Bondock
Samir Bondock
NANada Alabbad
Nada Alabbad
AHAisha Hossan
Aisha Hossan
Moaz M. AbdouMoaz M. Abdou
Moaz M. Abdou
ASAli A. Shati
Ali A. Shati
NMNada M. Mohamed
Nada M. Mohamed
A series of novel coumarin–thiazoles was designed and synthesized as a possible CDK2 inhibitor with anticancer activity with low toxicity. The design relied on having hydrazine thiazole or its open-form thioamide to form H-bonds with the ATP binding site while coumarin maintained the crucial hydrophobic interactions for proper fitting. The biological evaluation revealed that the hydroxycoumarin-thiazole derivative 6c demonstrated the best inhibition with HepG2 and HCT116 IC50 2.6 and 3.5 μM, respectively. Similarly, its open thioamide chain congener 5c exhibited potent inhibition on MCF-7 and HepG2 with IC50 of 4.5 and 5.4 μM, respectively. Molecular docking simulations supported the assumption of inhibiting CDK2 by preserving the crucial interaction pattern with the hinge ATP site and the surrounding hydrophobic (HPO) side chains. Furthermore, molecular dynamics simulations of 5c and 6c established satisfactory stability and affinity within the CDK2 active site.

18 October 2022 in Molecules
Verified
Journal Article
Open access
PDF file
NSNourhan Hisham Shady
Nourhan Hisham Shady
AAAbdullah H. Altemani
Abdullah H. Altemani
FAFaisal H. Altemani
Faisal H. Altemani
SASherif Ali
Sherif Ali
MEMahmoud A. Elrehany
Mahmoud A. Elrehany
SMSoad A. Mohamad
Soad A. Mohamad
Aphthous ulcers are very common disorders among different age groups and are very noxious and painful. The incidence of aphthous ulcer recurrence is very high and it may even last for a maximum of 6 days and usually, patients cannot stand its pain. This study aims to prepare a buccoadhesive fast dissolving film containing Corchorus olitorius seed extract to treat recurrent minor aphthous ulceration (RMAU) in addition to clinical experiments on human volunteers. An excision wound model was used to assess the in vivo wound healing potential of Corchorus olitorius L. seed extract, with a focus on wound healing molecular targets such as TGF-, TNF-, and IL-1. In addition, metabolomic profiling using HR-LCMS for the crude extract of Corchorus olitorius seeds was explored. Moreover, molecular docking experiments were performed to elucidate the binding confirmation of the isolated compounds with three molecular targets (TNF-α, IL-1β, and GSK3). Additionally, the in vitro antioxidant potential of C. olitorius seed extract using both H2O2 and superoxide radical scavenging activity was examined. Clinical experiments on human volunteers revealed the efficiency of the prepared C. olitorius seeds buccal fast dissolving film (CoBFDF) in relieving pain and wound healing of RMAU. Moreover, the wound healing results revealed that C. olitorius seed extract enhanced wound closure rates (p ≤ 0.001), elevated TGF-β levels and significantly downregulated TNF-α and IL-1β in comparison to the Mebo-treated group. The phenotypical results were supported by biochemical and histopathological findings, while metabolomic profiling using HR-LCMS for the crude extract of Corchorus olitorius seeds yielded a total of 21 compounds belonging to diverse chemical classes. Finally, this study highlights the potential of C. olitorius seed extract in wound repair uncovering the most probable mechanisms of action using in silico analysis.

4 August 2023 in RSC Advances
Verified
Journal Article
Open access
PDF file
SBSamir Bondock
Samir Bondock
TATallah Albarqi
Tallah Albarqi
MAMohamed Abboud
Mohamed Abboud
TNTamer Nasr
Tamer Nasr
NMNada M. Mohamed
Nada M. Mohamed
Moaz M. AbdouMoaz M. Abdou
Moaz M. Abdou
A novel series of 2,4,5- and 2,3,4-trisubstituted thiazole hybrids with 1,3,4-thiadiazolylbenzenesulfonamide was designed following the tail approach as possible hCAIX inhibitors. The key intermediate 1 was condensed with thiosemicarbazide 2a to give 1,3,4-thiadiazolylthiosemicarbazone 3, which upon hetero-cyclization with substituted α-haloketones and esters afforded 2,4,5-trisubstituted thiazole-1,3,4-thiadiazole conjugates 4–8. Furthermore, the trisubstituted thiazole-1,3,4-thiadiazole hybrids 12a–d were synthesized via the regioselective cyclization of 4-substituted-1,3,4-thiadiazolylthiosemicarbazones with phenacyl bromide. The cyclized 2,4-disubstituted thiazole 4 enhanced cytotoxicity by nine, four and two times against HepG-2, Caco2, and MCF-7, respectively. Moreover, the simple methyl substitution on the thiosemicarbazone terminus 9a improved the parent derivative 3 cytotoxicity by nine, fourteen, and six times against HepG-2, Caco2, and MCF-7, respectively. This astonishing cytotoxicity was elaborated with hCAIX molecular docking simulation of 4, 9a, and 12d demonstrating binding to zinc and its catalytic His94. Furthermore, molecular dynamic simulation 9a revealed stable hydrogen bonding with hCAIX with interaction energy of −61.07 kcal mol−1 and ΔGbinding MM-PBSA of −9.6 kcal mol−1.

30 October 2023 in New Journal of Chemistry
Verified
Journal Article
Closed access
PDF file
SBSamir Bondock
Samir Bondock
TATallah Albarqi
Tallah Albarqi
Moaz M. AbdouMoaz M. Abdou
Moaz M. Abdou
NMNada M. Mohamed
Nada M. Mohamed
Thiadiazole benzenesulfonamide derivatives 8c and 8e showed the best HepG-2 IC50 of 11.80 and 4.08 μM, respectively with corresponding VEGFR-2 ΔGbinding, −9.1 and −9.8 kcal mol−1, respectively.

2 February 2023 in Journal of Enzyme Inhibition and Medicinal Chemistry
Verified
Journal Article
Open access
MAMohammad M. Al-Sanea
Mohammad M. Al-Sanea
TNTamer M. Nasr
Tamer M. Nasr
SBSamir Bondock
Samir Bondock
AGAya Y. Gawish
Aya Y. Gawish
NMNada M. Mohamed
Nada M. Mohamed
Bis-thiazole derivatives were synthesised conforming to the Pim1 pharmacophore model following Hantzsch condensation. Pim1 has a major role in regulating the G1/S phase which upon inhibition the cell cycle stops at its early stages. Derivatives 3b and 8b showed the best Pim1 IC50 0.32 and 0.24 µM, respectively relative to staurosporine IC50 0.36 µM. Further confirmation of 3b and 8b Pim1 inhibition was implemented by hindering the T47D cell cycle at G0/G1 and S phases where 3b showed 66.5% cells accumulation at G0/G1 phase while 8b demonstrated 26.5% cells accumulation at the S phase compared to 53.9% and 14.9% of a control group for both phases, respectively. Additional in vivo cytotoxic evaluation of 3b and 8b revealed strong antitumor activity with up-regulation of caspase-3 and down-regulation of VEGF and TNF α immune expression with concomitant elevation of malondialdehyde levels in case of 8b.